JCRファーマ株式会社

Biopharmaceutical Pioneer in Japan

JCR has been proactively engaged in research and development (R&D) of biopharmaceuticals based on recombinant DNA technologies from early on as a Japanese pharmaceutical company. In 1993, the recombinant human growth hormone product, Growject®, was launched.Learn more

Top page